Clinical trial
VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis
NCT00314990 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00314990 |
|---|---|
| Title | VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis |
| Official title | Homocysteine Lowering by B Vitamins and the Secondary Prevention of Deep-Vein Thrombosis and Pulmonary Embolism. A Randomized, Placebo-Controlled, Double Blind Trial. |
| Lead sponsor | Radboud University Medical Center, Other |
| Collaborators | Netherlands Heart Foundation |
| Status | Completed |
| Study type | Interventional |
| Conditions | Deep-Vein Thrombosis, Pulmonary Embolism |
| Intervention type | Drug |
| Interventions | 5 mg folic acid, 50 mg pyridoxine and 0.4 mg cyanocobalamin |
| Enrollment | 620 |
| Start date | Jan 1, 1996 |
| Completion | Jan 1, 2003 |
| First posted | Apr 17, 2006 |
| Last update posted | Apr 17, 2006 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: